Business Wire

IL-FOURKITES

14.3.2024 12:31:31 CET | Business Wire | Press release

Share
FourKites Elevates Executives to Drive Industry Adoption and Accelerate Customer Value

Leading real-time supply chain visibility provider FourKites® today announced the promotion of Priya Rajagopalan to President of Product, Technology and Operations, as well as the appointment of Ron Richardson as Chief Revenue Officer (CRO). These appointments underscore FourKites’ focus on rapid growth and innovation, with an eye toward solving customers’ most pressing needs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240314808596/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

FourKites promotes Priya Rajagopalan to President of Product, Technology and Operations and appoints Ron Richardson as Chief Revenue Officer to drive industry adoption and accelerate customer value (Photo: Business Wire)

Priya Rajagopalan leads FourKites’ Product, Engineering and Customer functions, with the goal of aligning customer needs and the company’s innovation engine to drive maximum customer value. Rajagopalan joined FourKites seven years ago as Chief Product Officer, bringing with her a wealth of experience in product management from various startups and public companies. Currently, Rajagopalan also serves on the Board of Directors of Brambles (ASX: BXB), the supply-chain logistics company operating across 60 countries through the CHEP brand. A testament to her industry contributions, she has been named an SDCE Pros to Know, and one of The Software Report’s Top 25 Software Product Executives.

Under Rajagopalan’s direction, FourKites has rolled out a number of industry-first product innovations, including real-time facility manager Dynamic Yard; end-to-end international ocean shipments tracker Dynamic Ocean; generative AI assistant Fin AI; patented AI-powered ETA forecaster Smart Forecasted Arrival; universal appointment scheduler Appointment Manager; and others.

“FourKites defined and created the supply chain visibility category, and innovating with customers has been, and continues to be part of our company’s DNA,” said Rajagopalan. “This alignment allows us to innovate and execute at even greater speed to ensure successful deployment and adoption across our customers."

Ron Richardson returns to FourKites as CRO, where he leads Sales, Partners and Alliances to drive FourKites’ global momentum. Ron recently served as CRO at OneRail, a solution that has redefined last-mile delivery, as well as CRO at Turvo, where he helped scale the company revenue and position it for a successful exit. Previously, Richardson was one of FourKites’ first employees, where he was instrumental in creating the real-time transportation visibility platform (RTTVP) category, building the business and closing some of the company’s earliest customer deals, including Coca-Cola, Nestlé and many more.

“I am thrilled to come back home to FourKites — returning to the market-leading company and the industry category I helped pioneer,” said Richardson. “I look forward to building on the momentum the team and I jump-started in the early years, driving growth and success among our Fortune 500 enterprise customers who continue to see massive value with the FourKites platform.”

“These promotions reflect our confidence in Priya’s and Ron’s leadership and their ability to propel FourKites to even greater heights,” said FourKites founder and CEO Mathew Elenjickal. “Priya’s unique blend of deep technical knowledge, innate leadership skills and collaborative approach has earned her admiration from industry leaders, investors and customers alike. Likewise, Ron brings deep industry experience, a strong track record as a successful CRO and, most importantly, vast knowledge of our existing customers and ecosystem. Under their leadership, we will continue to innovate, grow and solidify our position as the de-facto leader in the supply chain visibility space.”

About FourKites

Leading global supply chain visibility platform FourKites® empowers business leaders with comprehensive visibility into transportation, yards, warehouses, stores and beyond. Tracking more than 3.2 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitize their end-to-end supply chains. More than 1,500 of the world’s most recognized brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240314808596/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye